Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 42.12
+0.05 (0.12%)
At close: Mar 6, 2026
Lifecome Biochemistry Market Cap
Lifecome Biochemistry has a market cap or net worth of 6.55 billion as of March 6, 2026. Its market cap has increased by 178.39% in one year.
Market Cap
6.55B
Enterprise Value
7.63B
Revenue
587.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.12
Market Cap Chart
Since May 3, 2017, Lifecome Biochemistry's market cap has increased from 2.63B to 6.55B, an increase of 149.20%. That is a compound annual growth rate of 10.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.55B | 24.95% |
| Dec 31, 2025 | 5.24B | 68.80% |
| Dec 31, 2024 | 3.10B | -4.84% |
| Dec 29, 2023 | 3.26B | -59.95% |
| Dec 30, 2022 | 8.14B | 381.32% |
| Dec 31, 2021 | 1.69B | -17.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 7.26B |
| Wuhan Keqian Biology Co.,Ltd | 7.23B |
| Jiangsu Aidea Pharmaceutical Group | 6.93B |
| Shenzhen Weiguang Biological Products | 6.57B |
| Beijing Konruns Pharmaceutical | 6.50B |
| Shanghai OPM Biosciences | 6.37B |
| R&G PharmaStudies | 6.30B |
| Xiangxue Pharmaceutical | 6.25B |